Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positiv
ClinicalTrials.gov study NCT02132949. IPD Sharing: Not stated. Countries: 12. Publications: 1.
A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT00976989. IPD Sharing: Not stated. Countries: 20. Publications: 4.
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-
ClinicalTrials.gov study NCT01663727. IPD Sharing: Not stated. Countries: 16. Publications: 2.
A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
ClinicalTrials.gov study NCT01641939. IPD Sharing: Not stated. Countries: 28. Publications: 2.
A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients
ClinicalTrials.gov study NCT01764022. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer
ClinicalTrials.gov study NCT04224272. IPD Sharing: NO. Countries: 3. Publications: 1.
A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer
ClinicalTrials.gov study NCT02795988. IPD Sharing: NO. Countries: 7. Publications: 2.
Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Meta
ClinicalTrials.gov study NCT00463788. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)
ClinicalTrials.gov study NCT03974022. IPD Sharing: NO. Countries: 13. Publications: 2.
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
ClinicalTrials.gov study NCT04569747. IPD Sharing: YES. Countries: 1. Publications: 1.
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT03633331. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
ClinicalTrials.gov study NCT02630693. IPD Sharing: YES. Countries: 1. Publications: 1.
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT03199885. IPD Sharing: YES. Countries: 2. Publications: 1.
Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer
ClinicalTrials.gov study NCT00470704. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KE
ClinicalTrials.gov study NCT03615326. IPD Sharing: YES. Countries: 20. Publications: 4.
A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)
ClinicalTrials.gov study NCT01926886. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT00333775. IPD Sharing: Not stated. Countries: 24. Publications: 1.
A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer
ClinicalTrials.gov study NCT04739761. IPD Sharing: YES. Countries: 18. Publications: 1.
A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)
ClinicalTrials.gov study NCT02187744. IPD Sharing: YES. Countries: 10. Publications: 1.
A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Ther
ClinicalTrials.gov study NCT01419197. IPD Sharing: Not stated. Countries: 22. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.